I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Fries, W.
916
results:
OpenAccess-fulltext X
Search for persons
X
Languages
english (763)
german (11)
more...
portuguese (2)
dutch (1)
less...
Sorted by: Relevance
Sorted by: Year
?
1
Use of biologics for the management of Crohn's disease: IG-..:
Macaluso F. S
;
Papi C
;
Orlando A
...
info:eu-repo/semantics/altIdentifier/pmid/36792429. , 2023
Link:
https://hdl.handle.net/2..
?
2
Efficacy and Safety of Biological Therapies and JAK Inhibit..:
Fries W
;
Basile G
;
Bellone F
..
info:eu-repo/semantics/altIdentifier/pmid/37443755. , 2023
Link:
https://hdl.handle.net/1..
?
3
Low Adherence is Associated with Chronic Active Disease in ..:
Viola A
;
Demarzo MG
;
Abbruzzese A
...
https://www.dovepress.com/low-adherence-is-associated-with-chronic-active-disease-in-ulcerative--peer-reviewed-fulltext-article-PPA. , 2023
Link:
https://doaj.org/article..
?
4
Effectiveness and safety of vedolizumab in a matched cohort..:
Pugliese D
;
Privitera G
;
Crispino F
...
info:eu-repo/semantics/altIdentifier/pmid/35876062. , 2022
Link:
http://hdl.handle.net/23..
?
5
Use of biologics and small molecule drugs for the managemen..:
Macaluso F. S
;
Orlando A
;
Papi C
...
info:eu-repo/semantics/altIdentifier/pmid/35184989. , 2022
Link:
http://hdl.handle.net/23..
?
6
Use of biologics and small molecule drugs for the managemen..:
Macaluso F. S
;
Orlando A
;
Papi C
...
info:eu-repo/semantics/altIdentifier/pmid/35184989. , 2022
Link:
http://hdl.handle.net/24..
?
7
Use of biologics and small molecule drugs for the managemen..:
Macaluso F. S
;
Orlando A
;
Papi C
...
info:eu-repo/semantics/altIdentifier/pmid/35184989. , 2022
Link:
https://hdl.handle.net/1..
?
8
Use of biologics and small molecule drugs for the managemen..:
Macaluso F. S
;
Orlando A
;
Papi C
...
info:eu-repo/semantics/altIdentifier/pmid/35184989. , 2022
Link:
http://hdl.handle.net/11..
?
9
An Objective Comparison of Vedolizumab and Ustekinumab Effe..:
Onali S
;
Pugliese D
;
Caprioli F. A
...
info:eu-repo/semantics/altIdentifier/pmid/35467558. , 2022
Link:
http://hdl.handle.net/23..
?
10
Effectiveness and safety of vedolizumab in a matched cohort..:
Pugliese D
;
Privitera G
;
Crispino F
...
info:eu-repo/semantics/altIdentifier/pmid/35876062. , 2022
Link:
https://hdl.handle.net/1..
?
11
Red flags for appropriate referral to the gastroenterologis..:
Felice C
;
Leccese P
;
Scudeller L
...
info:eu-repo/semantics/altIdentifier/pmid/30554407. , 2019
Link:
http://hdl.handle.net/11..
?
12
Red flags for appropriate referral to the gastroenterologis..:
Felice C
;
Leccese P
;
Scudeller L
...
info:eu-repo/semantics/altIdentifier/pmid/30554407. , 2019
Link:
http://hdl.handle.net/11..
?
13
The PROSit cohort of infliximab biosimilar in IBD: A prolon..:
Armuzzi A
;
Fiorino G
;
Variola A
...
info:eu-repo/semantics/altIdentifier/pmid/30137352. , 2019
Link:
http://hdl.handle.net/11..
?
14
Unmet medical needs in the management of ulcerative colitis..:
Daperno M
;
Armuzzi A
;
Danese S
...
info:eu-repo/semantics/altIdentifier/pmid/31565051. , 2019
Link:
http://hdl.handle.net/11..
?
15
Safety of treatments for inflammatory bowel disease: Clinic..:
Biancone L
;
Annese V
;
Ardizzone S
...
info:eu-repo/semantics/altIdentifier/pmid/28161290. , 2017
Link:
http://hdl.handle.net/11..
1-15
